International Journal of Dermatology and Venereology

Aims & Scope

International Journal of Dermatology and Venerology intends to provide international clinicians and researchers with an open forum, further to disseminate important/new information and promote academic communications in all aspects of dermatology and venereology, including epidemiology, etiology, diagnosis, treatment, and management of skin disorders.

Manuscripts with clinical and public health implications and manuscripts with innovative ideas and/or approaches that bridge different fields are considered with priority.

The Journal is both sponsored by Hospital for Skin Diseases (Institute of Dermatology), Chinese Academy of Medical Sciences & Peking Union Medical College (hereinafter, the "Hospital"), and Chinese Medical Association.

The Hospital is also functionally acting as the National Center for STD Control and National Center for Leprosy Control, World Health Organization (WHO) Collaborating Center for Prevention and Control of STDs, the Medical Mycology Center of the China Committee for Culture Collection of Microorganisms (CCCCM) .

Chinese Medical Association is the top medical association in China, and has the biggest medical publish group.

The sponsors provide the Journal adequate academic and technical support.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Plagiarism url
• Preservation url
• Apc url

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal does not charge a mandatory Article Processing Charge (APC). However, optional open access publication may incur fees based on the publisher’s policies.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Prevention and Treatment of Skin Damage Caused by Personal Protective Equipment: Experience of the First-Line Clinicians Treating SARS-CoV-2 Infection

  Citation: 47

  Authors: Nuo-Ya, Liu, Li-Yun, Yan, Xiang-Jie, Jing, Liu, Chang-Zheng, Juan

• The Immune Function of Keratinocytes in Anti-Pathogen Infection in the Skin

  Citation: 28

  Authors: Jia-Ning, Min

• Chinese Guidelines for the Management of Acne Vulgaris: 2019 Update #

  Citation: 26

  Authors:

• Guidelines for Diagnosis and Treatment of Atopic Dermatitis in China (2020)#

  Citation: 24

  Authors: Xu, Zhi-Qiang, Wei, Yun-Sheng, Yan, Hua, Tao, Xue, Ai-Ping, Song-Mei, Heng, Shu-Ping, Yan-Ling, Ye-Hong, Chun-Ying, Xiao-Hong, Zheng-Xiao, Jun-Qin, Hong-Ye, Ling-Ling, Yu-Mei, Zhi, Hai, Qian-Jin, Yan, Xiao-Qun, Xiao-Yan, Lin, Zhu, Xin, Zhong-Xiang, Xiang-Yang, Qing, Jian-Ping, Ao-Xue, Hui-Ping, Jian-Qin, Ming-Yue, Zai-Xing, Yu-Min, Ting, Zhi-Qiang, Huan, Ying, Zi-Gang, Bin, Zhi-Rong, Jian-Bin, Nan, Kang, Jian-Zhong, Jun-Ling, Hua, Zuo-Tao, Wei, Ying-Hua, Ying

• Guidelines for the Diagnosis and Treatment of Psoriasis in China: 2019 Concise Edition#

  Citation: 21

  Authors:

• Consensus on the Diagnosis and Treatment of Vitiligo in China (2021 Revision)#

  Citation: 19

  Authors: Tie-Chi, Ai-E, Tian-Wen, Li, Hua, Ming, Tie-Nan, Chun-Ying, Tong, Kuan-Hou, Chai-Xia, Hai, Ji-Yuan, Jun-Ling, Zhi-Zhong

• Pathogenesis of Photoaging in Human Dermal Fibroblasts

  Citation: 18

  Authors: Ling-Yi, Sheng-Xiu

• Epidemiological Characteristics of Leprosy in China, 2018

  Citation: 15

  Authors: Le, Pei-Wen, Mei-Wen, Heng, Hong-Sheng, Xiang-Sheng

• Efficacy and Safety of Ixekizumab in Chinese Patients With Moderate-to-Severe Plaque Psoriasis: 60-Week Results From a Phase 3 Study

  Citation: 15

  Authors: Xia, Jie, Wei-Li, Min, Yan, Fu-Qiu, Yang-Feng, Jian-Zhong, Hong-Ying, Wen-Long

• The Association of Psoriasis and Obesity: Focusing on IL-17A-Related Immunological Mechanisms

  Citation: 13

  Authors: Cheng, Jie, Ting, Hong-Wei, Zhong-Lan